NW3-26590-79757
4 vaccinations
1 coded response
44 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 208 / MD
- Registered
- 2021-04-08
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-04-08
Registered in v-safe
-
2021-04-08
Dose 1 — Pfizer-BioNTech
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-22
-
2021-04-29
Dose 2 — Pfizer-BioNTech
-
2021-04-29
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body achesAdult check-in
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-15
- 2021-05-22
- 2021-05-27
- 2021-06-03
- 2021-06-12
- 2021-07-31
- 2021-10-28
-
2021-12-21
Dose 3 — Moderna
- 2021-12-21
- 2021-12-22
- 2021-12-23
- 2021-12-24
- 2021-12-25
- 2021-12-26
- 2021-12-27
- 2021-12-28
- 2022-01-04
- 2022-01-11
- 2022-01-18
- 2022-01-25
- 2022-02-03
- 2022-03-24
-
2022-06-21
Survey response — 6 months, dose 3MedDRA: Breakthrough COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid breakthrough infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-06-21
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-06-22
-
2022-09-10
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-11
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
- 2022-09-19
- 2022-09-24
- 2022-10-01
- 2022-12-10
- 2023-03-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Pfizer-BioNTech | |
| 2 | 2021-04-29 | Pfizer-BioNTech | |
| 3 | 2021-12-21 | Moderna | No |
| 4 | 2022-09-10 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — 6 months, dose 3
Symptoms: Covid breakthrough infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Breakthrough COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release